Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.

Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.

Item
http://www.wikidata.org/entity/Q35813930
Rivastigmine for dementia in people with Down syndromeMemantine for dementia in people with Down syndromeGalantamine for dementia in people with Down syndromeDonepezil for dementia in people with Down syndromeSafety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study.Age-related neurodegeneration and memory loss in down syndrome.An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.Atypical aging in Down syndrome.Pharmacotherapeutic Considerations for Individuals with Down Syndrome.Cognitive enhancement therapy for a model of Down syndrome.Ameliorating Effects of Ethanol Extract of Fructus mume on Scopolamine-Induced Memory Impairment in Mice.Dramatic improvement in Down syndrome-associated cognitive impairment with donepezil.Consensus statement of the international summit on intellectual disability and Dementia related to post-diagnostic support.Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities.The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome.
P2860

Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.

Item
http://www.wikidata.org/entity/Q35813930
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Review of donepezil, rivastigm ...... lectual disability population.
@ast
Review of donepezil, rivastigm ...... lectual disability population.
@en
type
label
Review of donepezil, rivastigm ...... lectual disability population.
@ast
Review of donepezil, rivastigm ...... lectual disability population.
@en
prefLabel
Review of donepezil, rivastigm ...... lectual disability population.
@ast
Review of donepezil, rivastigm ...... lectual disability population.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Review of donepezil, rivastigm ...... lectual disability population.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921